Market Overview

Forest Laboratories Cuts 2013 Profit View: Shares Drop In Pre-Market Trading

Related FRX
Icahn's (Potential) Move Into Biotech
Carl Icahn's Track Record In Big Pharma

Shares of Forest Laboratories Inc (NYSE: FRX) dropped more than 7% in pre-market trading after the company cut its 2013 profit forecast.

Forest Laboratories cut its 2013 profit forecast to $0.65 to $0.80 per share, versus analysts' estimates of $1 per share.

FRX shares declined 7.96% to $32.85 in the pre-market session.

Posted-In: movers and shakersEarnings News Guidance Pre-Market Outlook


Related Articles (FRX)

View Comments and Join the Discussion!